GSDMD and atherosclerosis: The 12-week-old WT and GsdmD–/– KO mice were injected i.p. with LDLr ASO or control ASO once a week for 9 weeks and mice were fed an atherogenic WTD throughout the study, as shown in the atherosclerosis study design (Figure 5A).